Seastar Medical Holding Corporation

Seastar Medical Holding Corporation is a medical device company focused on developing innovative products to address life-threatening diseases with acute kidney and sepsis conditions. The primary function of Seastar Medical is to create advanced therapies that can save lives, specifically focusing on providing critical care solutions that address severe inflammatory conditions. The company’s pivotal product revolves around therapeutic devices that support acute needs in the intensive care unit, particularly for the treatment of acute kidney injury (AKI) and cytokine storm, conditions often resulting from severe infections or other critical conditions. Through collaboration with leading healthcare institutions and leveraging cutting-edge research, Seastar Medical aims to deliver effective treatment solutions that impact both the acute kidney injury and broader intensive care market. The company operates in a high-stakes sector, necessitating rigorous regulatory compliance and clinical validation of its products. Headquartered in the United States, Seastar Medical Holding Corporation remains committed to enhancing patient outcomes by developing targeted therapies that address significant unmet medical needs, positioning it as a key player in the transformative healthcare technologies landscape.